Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging Study

Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging Study

(1) Background: Natalizumab dramatically reduces relapses and MRI inflammatory activity (new lesions and enhancing lesions) in multiple sclerosis (MS). Chemical exchange saturation transfer (CEST) MRI can explore brain tissue in vivo with high resolution and sensitivity. We investigated if natalizum...

Full description

Bibliographic Details
Main Authors: Radu Tanasescu, Olivier Mougin, I-Jun Chou, Ali Al-Radaideh, Oltita P. Jerca, Su-Yin Lim, Penny Gowland, Cris S. Constantinescu
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Brain Sciences
Subjects:
multiple sclerosis
ultra-high-field MRI
natalizumab
normal-appearing white matter
Online Access:https://www.mdpi.com/2076-3425/13/10/1464

Internet

https://www.mdpi.com/2076-3425/13/10/1464

Similar Items